New Delhi, May 8: Ranbaxy Laboratories, India's largest drugmaker by sales, posted a 90 per cent drop in first quarter net profit compared to the same year-ago period.
Ranbaxy's consolidated net profit fell to Rs 126 crore in the fiscal first quarter ended March, from Rs. 1,247 crore last year. Sales fell 34.2 per cent to Rs. 2,440 crore.
